Salem Capital Management’s Amgen AMGN Stock Holding History

Salem Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,100	Closed	-$274K	–	76
2021 Q1	$274K	Hold	1,100	–	–	0.16%	61
2020 Q4	$253K	Hold	1,100	–	–	0.16%	60
2020 Q3	$280K	Hold	1,100	–	–	0.2%	57
2020 Q2	$259K	Hold	1,100	–	–	0.19%	58
2020 Q1	$223K	Hold	1,100	–	–	0.18%	60
2019 Q4	$265K	Hold	1,100	–	–	0.14%	61
2019 Q3	$213K	Hold	1,100	–	–	0.12%	68
2019 Q2	$203K	Hold	1,100	–	–	0.11%	71
2019 Q1	$209K	Hold	1,100	–	–	0.11%	69
2018 Q4	$214K	Hold	1,100	–	–	0.13%	64
2018 Q3	$228K	Hold	1,100	–	–	0.12%	63
2018 Q2	$203K	Buy	+1,100	New	+$195K	0.11%	68
2017 Q4	–	Sell	-1,200	Closed	-$224K	–	69
2017 Q3	$224K	Hold	1,200	–	–	0.12%	68
2017 Q2	$207K	Buy	+1,200	New	+$195K	0.12%	65
2016 Q4	–	Sell	-1,200	Closed	-$200K	–	65
2016 Q3	$200K	Buy	+1,200	New	+$203K	0.11%	64

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Salem Capital Management's AMGN Position: Q2 2021 in Review

Salem Capital Management sold out of Amgen (AMGN) in Q2 2021, closing a stake of 1,100 shares — an estimated $274K sold.

Salem Capital Management first reported a position in AMGN in Q3 2016 and held it in 15 quarters. The position peaked at $280K in Q3 2020. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

Salem Capital Management reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
Salem Capital Management sold 1,100 Amgen shares in Q2 2021, an estimated $274K.
Salem Capital Management first reported a position in Amgen in Q3 2016 and held it in 15 quarters.
Salem Capital Management's Amgen position peaked at $280K in Q3 2020.
2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Salem Capital Management's 13F filing for Q2 2021, filed 13 Jul 2021.